TRANYLCYPROMINE SULFATE

Post-LOE

tranylcypromine

Novitium Pharma

ANDAORALTABLET

Approved

Apr 2018

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

Drug data last refreshed 15h ago

$0.0BPart D

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Novitium Pharma

See all Novitium Pharma products →

Worked on TRANYLCYPROMINE SULFATE at Novitium Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.